Synergistic effects of recombinant human soluble thrombomodulin and fluid-volume resuscitation in a rat lethal crush injury model

Shock

Volumn 26, Issue 6, 2006, Pages 581-586

  Mohri, Tomoyoshi ^a   Tanaka, Hiroshi ^a   Tajima, Goro ^a   Kajino, Kentaro ^a   Sonoi, Hideaki ^a   Hosotsubo, Hideo ^a   Ogura, Hiroshi ^a   Kuwagata, Yasuyuki ^a   Shimazu, Takeshi ^a   Sugimoto, Hisashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Combination therapy; Hindlimbs; Inflammation; Ischemia reperfusion model; Normal saline; Prophylactic treatment

Indexed keywords

CREATINE KINASE; CREATININE; INTERLEUKIN 6; LACTIC ACID; MYOGLOBIN; NITROGEN; POTASSIUM; RECOMBINANT THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CRUSH TRAUMA; FLUID RESUSCITATION; HEMOCONCENTRATION; HYPERKALEMIA; LACTATE BLOOD LEVEL; MALE; MORTALITY; MUSCLE INJURY; NONHUMAN; POTASSIUM BLOOD LEVEL; PROPHYLAXIS; RAT; STATISTICAL ANALYSIS; SURVIVAL; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; FLUID THERAPY; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY; LACTATES; MALE; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REPERFUSION INJURY; RESUSCITATION; THROMBOMODULIN; TIME FACTORS; WOUNDS AND INJURIES;

EID: 33751216146     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000233198.48612.6b     Document Type: Article

References (37)

1. Erek E, Sever MS, Serdengecti K, Vanholder R, Akoglu E, Yavuz M, Ergin H, Tekce M, Duman N, Lameire N: An overview of morbidity and mortality in patients with acute renal failure due to crush syndrome: the Marmara earthquake experience. Nephrol Dial Transplant 17:33-40, 2002.
2. Ersoy A, Yavuz M, Usta M, Ercan I, Aslanhan I, Gullulu M, Kurt E, Emir G, Dilek K, Yurtkuran M: Survival analysis of the factors affecting in mortality in injured patients requiring dialysis due to acute renal failure during the Marmara earthquake: survivors vs non-survivors. Clin Nephrol 59:334-340, 2003.
3. Tanaka H, Oda J, Iwai A, Kuwagata Y, Matsuoka T, Takaoka M, Kishi M, Morimoto F, Ishikawa K, Mizushima Y, et al: Morbidity and mortality of hospitalized patients after the 1995 Hanshin-Awaji earthquake. Am J Emerg Med 17:186-191, 1999.
4. Smith J, Greaves I: Crush injury and crush syndrome: a review. J Trauma 54:S226-S230, 2003.
5. Better OS, Abassi Z, Rubinstein I, Marom S, Winaver Y, Silberman M: The mechanism of muscle injury in the crush syndrome: ischemic versus pressure-stretch myopathy. Miner Electrolyte Metab 16:181-184, 1990.
6. Odeh M: The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 324:1417-1422, 1991.
7. Better OS, Rubinstein I: Management of shock and acute renal failure in casualties suffering from the crush syndrome. Ren Fail 19:647-653, 1997.
8. Nadjafi I, Atef MR, Broumand B, Rastegar A: Suggested guidelines for treatment of acute renal failure in earthquake victims. Ren Fail 19:655-664, 1997.
9. Shimazu T, Yoshioka T, Nakata Y, Ishikawa K, Mizushima Y, Morimoto F, Kishi M, Takaoka M, Tanaka H, Iwai A, et al: Fluid resuscitation and systemic complications in crush syndrome: 14 Hanshin-Awaji earthquake patients. J Trauma 42:641-646, 1997.
10. Sever MS, Erek E, Vanholder R, Yurugen B, Kantarci G, Yavuz M, Ergin H, Bozfakioglu S, Dalmak S, Tulbek MY, et al: Renal replacement therapies in the aftermath of the catastrophic Marmara earthquake. Kidney Int 62:2264-2271, 2002.
11. Van de Wouwer M, Conway EM: Novel functions of thrombomodulin in inflammation. Crit Care Med 32:S254-S261, 2004.
12. Tsiang M, Lentz SR, Sadler JE: Functional domains of membrane-bound human thrombomodulin. EGR-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem 267:6164-6170, 1992.
13. Franco RF, Reitsma PH: Genetic risk factors of venous thrombosis. Hum Genet 109:369-384, 2001.
14. Taylor FB Jr, Chang AC, Esmon CT, Hinshaw LB: Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock. Curr Stud Hematol Blood Transfus 58:8-14, 1991.
15. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001.
16. Levi M, Dorffler-Melly J, Reitsma P, Buller H, Florquin S, van der Poll T, Carmeliet P: Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice. Blood 101:4823-4827, 2003.
17. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, DeVriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, et al: The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 196:565-577, 2002.
18. Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, Yang HY, Wu HL: Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem 278:46750-46759, 2003.
19. Yamaguchi Y, Hisama N, Okajima K, Uchiba M, Murakami K, Takahashi Y, Yamada S, Mori K, Ogawa M: Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver. Hepatology 25:1136-1140, 1997.
20. Akimau P, Yoshiya K, Hosotsubo H, Takakuwa T, Tanaka H, Sugimoto H: New experimental model of crush injury of the hindlimbs in rats. J Trauma 58:51-58, 2005.
21. Mohri M, Oka M, Aoki Y, Gonda Y, Hirata S, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Ishida T, et al: Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 45:298-303, 1994.
22. Kuwagata Y, Oda J, Tanaka H, Iwai A, Matsuoka T, Takaoka M, Kishi M, Morimoto F, Ishikawa K, Mizushima Y, et al: Analysis of 2,702 traumatized patients in the 1995 Hanshin-Awaji earthquake. J Trauma 43:427-432, 1997.
23. Oda J, Tanaka H, Yoshioka T, Iwai A, Yamamura H, Ishikawa K, Matsuoka T, Kuwagata Y, Hiraide A, Shimazu T, et al: Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 42:470-475, 1997.
24. Gonzalez D: Crush syndrome. Crit Care Med 33:S34-S41, 2005.
25. Kramer GC: Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 54:S89-S99, 2003.
26. Attuwaybi B, Kozar RA, Gates KS, Moore-Olufemi S, Sato N, Weisbrodt NW, Moore FA: Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme oxygenase 1 enzyme. J Trauma 56:749-758, 2004.
27. Shukla A, Hashiguchi N, Chen Y, Coimbra R, Hoyt DB, Junger WG: Osmotic regulation of cell function and possible clinical applications. Shock 21:391-400, 2004.
28. Suzuki K, Hayashi T, Nishioka J, Kosaka Y, Zushi M, Honda G, Yamamoto S: A domain composed of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 264:4872-4876, 1989.
29. Arcaroli J, Fessler MB, Abraham E: Genetic polymorphisms and sepsis. Shock 24:300-312, 2005.
30. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, Uchimura T, Ida N, Yamazaki Y, Yamada S, et al: The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 115:1267-1274, 2005.
31. Star RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998.
32. Clavijo-Alvarez JA, Sims CA, Pinsky MR, Puyana JC: Monitoring skeletal muscle and subcutaneous tissue acid-base status and oxygenation during hemorrhagic shock and resuscitation. Shock 24:270-275, 2005.
33. Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, et al: Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 61:490-501, 2002.
34. Uchiba M, Okajima K, Murakami K, Johno M, Okabe H, Takatsuki K: Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats. Am J Hematol 54:118-123, 1997.
35. Uchiba M, Okajima K, Murakami K, Johno M, Mohri M, Okabe H, Takatsuki K: rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation. Am J Physiol 272:L889-L894, 1997.
36. Emig U, Schmidt G, Hellige G, Vetterlein F: Contribution of myoglobin-induced increases in vascular resistance to shock decompensation in experimental Crush-syndrome in anesthetized rats. Shock 19:79-84, 2003.
37. Mathru M, Lang JD: Endothelial dysfunction in trauma patients: a preliminary communication. Shock 24:210-213, 2005.